Alterity Therapeutics Limited (PRNAF)
OTCMKTS · Delayed Price · Currency is USD
0.0030
-0.0109 (-78.42%)
At close: Jun 16, 2025
Alterity Therapeutics Market Cap
Alterity Therapeutics has a market cap or net worth of $79.15 million as of September 18, 2025. Its market cap has increased by 525.90% in one year.
Market Cap
79.15M
Enterprise Value
52.35M
Revenue
3.57M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since March 28, 2000, Alterity Therapeutics's market cap has increased from 31.63M to 79.15M, an increase of 150.22%. That is a compound annual growth rate of 3.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2025 | 79.15M | 200.50% |
| Dec 31, 2024 | 26.34M | 96.98% |
| Dec 29, 2023 | 13.37M | -18.58% |
| Dec 30, 2022 | 16.42M | -55.31% |
| Dec 31, 2021 | 36.75M | -24.34% |
| Dec 31, 2020 | 48.57M | 296.15% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 806.69M |
| Tian'an Technology Group | 792.01M |
| Elite Pharmaceuticals | 718.26M |
| Glass House Brands | 574.70M |
| CytoDyn | 377.06M |
| Northwest Biotherapeutics | 373.88M |
| American Oncology Network | 345.48M |